Rob Mould

Rob Mould is a Scientist II at Ensoma with a focus on Translational Biology, specializing in stem cell gene therapy and immuno-oncology. Prior to their current role, Rob held the position of Scientist I at the same company. With a background in cancer biotherapeutics and immunotherapy, Rob also worked as a Postdoctoral Researcher and PHD Candidate at the University of Guelph, where Rob developed viral and cell-based therapeutics for targeting cancer and infectious diseases. Rob holds a Doctor of Philosophy in Immunology and a Bachelor's degree in Biology/Biological Sciences.